drugset / Trial / NCT04871711

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema

NCT04871711

Phase 3 Completed 487 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This was a 16-week study in adult participants with chronic hand eczema (CHE). \> The participants visited the clinic regularly to have the study doctor assess their CHE and to answer questions about itch, pain, CHE symptoms, and quality of life. \> The purpose was to assess how delgocitinib cream works to treat CHE when compared to a placebo cream with no active substance.

Timeline

Start
2021-05-10
Primary completion
2022-10-31
Completion
2022-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Delgocitinib Small molecule 20 unknown Topical

Indications

No indication recorded.